Skip to main content
. 2024 Nov 28;27(2):710–718. doi: 10.1111/dom.16065

FIGURE 2.

FIGURE 2

Individual patient weight‐loss data at 1 year by baseline FPG (A), HbA1c (B), diabetes duration (C), C‐peptide (D), insulin (E) and HOMA‐IR (F) with semaglutide. FPG, fasting plasma glucose; HbA1c, glycated haemoglobin; HOMA‐IR, Homeostatic Model Assessment of Insulin Resistance.